| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |